Manufacturer
Astellas Pharma
Pharmaceutical manufacturer based in Japan
Japan
- Products listed
- 23
- Molecules
- 9
- Therapy areas
- 5
Astellas Pharma is a pharmaceutical manufacturer based in Japan. MedsAcross lists 23 of its products across 9 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Japan
- Indian manufacturer
- No
- Also listed as
- Astellas Pharma GmbH, Astellas Pharma US, Inc.
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Astellas Pharma products through licensed channels, with the documents your regulator needs.
Immunology and transplant
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Astagraf XL 0.5 mg extended-release capsuleOral | Tacrolimus | US FDA | Available on request |
| Astagraf XL 1 mg extended-release capsuleOral | Tacrolimus | US FDA | Available on request |
| Astagraf XL 5 mg extended-release capsuleOral | Tacrolimus | US FDA | Available on request |
| Prograf 0.2 mg oral suspensionOral | Tacrolimus | US FDA | Available on request |
| Prograf 0.5 mg capsuleOral | Tacrolimus | US FDA | Available on request |
| Prograf 1 mg oral suspensionOral | Tacrolimus | US FDA | Available on request |
| Prograf 1 mg capsuleOral | Tacrolimus | US FDA | Available on request |
| Prograf 5 mg capsuleOral | Tacrolimus | US FDA | Available on request |
| Prograf 5 mg/1 mL injectionIntravenous | Tacrolimus | US FDA | Available on request |
Oncology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Vyloy 20 mg/mL powder for injectable suspensionIntravenous | Zolbetuximab | US FDA | Available on request |
| Xospata 40 mg tabletOral | Gilteritinib | US FDA | Available on request |
| Xtandi 40 mg tabletOral | Enzalutamide | US FDA | Available on request |
| Xtandi 40 mg capsuleOral | Enzalutamide | US FDA | Available on request |
| Xtandi 80 mg tabletOral | Enzalutamide | US FDA | Available on request |
Nephrology and urology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Myrbetriq 25 mg extended-release tabletOral | Mirabegron | US FDA | Available on request |
| Myrbetriq 50 mg extended-release tabletOral | Mirabegron | US FDA | Available on request |
| Myrbetriq 8 mg/mL extended-release oral suspensionOral | Mirabegron | US FDA | Available on request |
Ophthalmology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Izervay 7 mg/0.35 mL injectionIntravitreal Cold chain | Avacincaptad pegol | US FDA | Available on request |
Cardiology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lexiscan 0.4 mg/5 mL injectionIntravenous | Regadenoson | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cresemba 100 mg capsuleOral | Isavuconazonium | US FDA | Available on request |
| Cresemba 40 mg capsuleOral | Isavuconazonium | US FDA | Available on request |
| Cresemba 40 mg/mL powder for injectionIntravenous | Isavuconazonium | US FDA | Available on request |
| Veozah 45 mg tabletOral | Fezolinetant | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Astellas Pharma
Send a request for any of these products. We confirm the licensed source, documents and lead time.